AI Med Artificial Intelligence Magazine masthead

AI-driven autism diagnosis aid receives FDA authorization

This article was originally published on AIMed in Feature: Real Life, 08/12/2021 Cognoa’s device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of enabling earlier interventions In June, the FDA granted a De Novo classification request to Canvas Dx, a machine learning-driven autism diagnostic solution, developed by pediatric behavioral health company…

Cognoa logo.

Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid

Cognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif. – June 2nd, 2021) – Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced…

Autism: Awareness, Acceptance, Action

By: Lani Hessen, Director of Advocacy, Cognoa, and Pediatric Occupational Therapist (OTR/L) Autism impacts an estimated 1 in 54 children in the U.S. today. Autism is a spectrum, representing a tremendous range of skills and challenges spanning learning and communication, socialization and developmental behaviors.  Autism impacts children and families of all backgrounds, regardless of race, ethnicity, location, or wealth. As…

Empowering Pediatricians to Diagnose Autism

By David Happel This article was originally published in Autism Parenting Magazine, Issue 118. Nearly 80 years after psychiatrist Leo Kanner became the first physician to use the term “autism”, children and families with autism still face critical gaps and unnecessary delays on their way to a diagnosis. Rather than diagnosing children themselves, pediatricians typically refer children with suspected developmental delays to specialists—setting…

photo of Eric Mosbrooker COO

Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer

Mosbrooker will be leading the operational and commercial efforts of Cognoa’s digital behavioral health products (Palo Alto, Calif. – January 14, 2021) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health conditions, today announced the appointment of Eric B. Mosbrooker as Chief Operations Officer. Mosbrooker will be…

Meet The Disruptors: David Happel of Cognoa On The Three Things You Need To Shake Up Your Industry

Written By Jason Hartman As a part of our series about business leaders who are shaking things up in their industry, I had the pleasure of interviewing David Happel. David Happel is the President and CEO of Cognoa, the leading digital diagnostics and therapeutics company developing FDA cleared pediatric behavioral health solutions. Prior to joining Cognoa, Happel served as President,…

Scary Mommy logo

From A Pediatrician: What To Do If You Think Your Child May Have ASD

by Katie Cloyd  – December 18, 2020 So, you think your young child might be on the autism spectrum. Maybe they’re not talking or communicating as expected, or they don’t seem to understand when you talk to them. Perhaps they seem exceptionally frustrated and their tantrum behaviors don’t seem developmentally typical to you. Like many other parents, I have been there. My son was…

This AI Tool For Diagnosing Autism Could Hit The Market ‘In The Second Half Of 2021’

Graison Dangor Contributor Healthcare I cover the intersection of mental health, the economy, and policy. A tool that helps pediatricians diagnose autism with artificial intelligence and smartphone video passed a key FDA test and could hit the market as soon as next summer, according to device-maker Cognoa, which recently announced its plans to submit the tool for final approval. In…

Cognoa moves ahead on FDA clearance of digital autism diagnostic

By Meg Bryant Children with autism spectrum disorder (ASD) can face a lifetime of frustration because of challenges with communication, social behaviors and flexibility of thought. Early intervention can improve outcomes, but nailing a diagnosis of ASD often takes years. Cognoa Inc. wants to change that with its digital ASD Diagnostic and is on track to apply for U.S. FDA clearance before the…

Cognoa’s AI-powered diagnostic app for autism clears clinical study, heads for FDA review

by Conor Hale Cognoa aims to equip primary care pediatricians with an artificial-intelligence-powered digital app that can spot the signs of autism, allowing them to rule out or diagnose spectrum disorders within the doctor’s office or remotely. This could represent a broad shift in the standard of care, as most children are referred to specialists for diagnosis and later treatment—a process…

Location

Social